BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 28009605)

  • 21. Uterine PEComas: A Morphologic, Immunohistochemical, and Molecular Analysis of 32 Tumors.
    Bennett JA; Braga AC; Pinto A; Van de Vijver K; Cornejo K; Pesci A; Zhang L; Morales-Oyarvide V; Kiyokawa T; Zannoni GF; Carlson J; Slavik T; Tornos C; Antonescu CR; Oliva E
    Am J Surg Pathol; 2018 Oct; 42(10):1370-1383. PubMed ID: 30001237
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Malignant perivascular epithelioid cell tumor (PEComa) of cervix with TFE3 gene rearrangement: a case report.
    Liu F; Zhang R; Wang ZY; Xia Q; Shen Q; Shi S; Tu P; Shi Q; Zhou X; Rao Q
    Int J Clin Exp Pathol; 2014; 7(9):6409-14. PubMed ID: 25337301
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Primary Xp11 translocation PEComa of the testis with SFPQ⁃TFE3 rearrangement: a case report and review of the literature.
    Zhang H; Wang S; Meng L
    Diagn Pathol; 2023 Jan; 18(1):6. PubMed ID: 36647137
    [TBL] [Abstract][Full Text] [Related]  

  • 24. TFE3-Expressing Perivascular Epithelioid Cell Neoplasm (PEComa) of the Sella Turcica.
    Hyrcza MD; Winer DA; Shago M; Au K; Zadeh G; Asa SL; Mete O
    Endocr Pathol; 2017 Mar; 28(1):22-26. PubMed ID: 27189222
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A distinctive subset of PEComas harbors TFE3 gene fusions.
    Argani P; Aulmann S; Illei PB; Netto GJ; Ro J; Cho HY; Dogan S; Ladanyi M; Martignoni G; Goldblum JR; Weiss SW
    Am J Surg Pathol; 2010 Oct; 34(10):1395-406. PubMed ID: 20871214
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Melanotic PEComa: A Rare But Distinctive Subtype Analyzed in a Series of 7 Cases.
    de la Fouchardiere A; Papke DJ; Pissaloux D; Russell-Goldman E; Tirode F; Fletcher CDM; Hanna J
    Am J Surg Pathol; 2024 Jan; 48(1):88-96. PubMed ID: 38117287
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Perivascular epithelioid cell tumor (PEComa) with TFE3 gene rearrangement: clinicopathological, immunohistochemical, and molecular features.
    Shen Q; Rao Q; Xia QY; Yu B; Shi QL; Zhang RS; Zhou XJ
    Virchows Arch; 2014 Nov; 465(5):607-13. PubMed ID: 25239799
    [TBL] [Abstract][Full Text] [Related]  

  • 28. TFE3 activation in a TSC1-altered malignant PEComa: challenging the dichotomy of the underlying pathogenic mechanisms.
    Schmiester M; Dolnik A; Kornak U; Pfitzner B; Hummel M; Treue D; Hartmann A; Agaimy A; Weyerer V; Lekaj A; Brakemeier S; Peters R; Öllinger R; Märdian S; Bullinger L; Striefler JK; Flörcken A
    J Pathol Clin Res; 2021 Jan; 7(1):3-9. PubMed ID: 33180365
    [TBL] [Abstract][Full Text] [Related]  

  • 29. PEComa with ASPSCR1::TFE3 fusion: expanding the molecular genetic spectrum of TFE3-rearranged PEComa with an emphasis on overlap with alveolar soft part sarcoma.
    Zhao M; Huang Y; Yin X; Xu J; Sun Y; Wang J
    Histopathology; 2024 Feb; 84(3):482-491. PubMed ID: 37936565
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Perivascular epithelioid cell tumor with SFPQ/PSF-TFE3 gene fusion in a patient with advanced neuroblastoma.
    Tanaka M; Kato K; Gomi K; Matsumoto M; Kudo H; Shinkai M; Ohama Y; Kigasawa H; Tanaka Y
    Am J Surg Pathol; 2009 Sep; 33(9):1416-20. PubMed ID: 19606011
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Xp11.2 translocation renal cell carcinoma with NONO-TFE3 gene fusion: morphology, prognosis, and potential pitfall in detecting TFE3 gene rearrangement.
    Xia QY; Wang Z; Chen N; Gan HL; Teng XD; Shi SS; Wang X; Wei X; Ye SB; Li R; Ma HH; Lu ZF; Zhou XJ; Rao Q
    Mod Pathol; 2017 Mar; 30(3):416-426. PubMed ID: 27934879
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Melanotic MiT family translocation neoplasms: Expanding the clinical and molecular spectrum of this unique entity of tumors.
    Saleeb RM; Srigley JR; Sweet J; Doucet C; Royal V; Chen YB; Brimo F; Evans A
    Pathol Res Pract; 2017 Nov; 213(11):1412-1418. PubMed ID: 28969862
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Malignant TFE3-rearranged perivascular epithelioid cell neoplasm (PEComa) presenting as a subcutaneous mass.
    Shon W; Kim J; Sukov W; Reith J
    Br J Dermatol; 2016 Mar; 174(3):617-20. PubMed ID: 26385848
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A rare case of TFE-related pigmented renal tumor with overlapping features between melanotic Xp11 translocation renal cancer and Xp11 renal cell carcinoma with melanotic features.
    Cardili L; Wrublevsky Pereira G; Viana CR
    Pathol Int; 2017 Apr; 67(4):208-213. PubMed ID: 28208226
    [TBL] [Abstract][Full Text] [Related]  

  • 35. TFE3-Expressing Epithelioid Rich Perivascular Epithelioid Cell Neoplasm (PEComa) of the Bladder with Unusual Benign Course.
    Chen XF; Yeong J; Chang KTE; Lim AST; Kuick CH; Lim TH; Sudhanshi J; Selvarajan S; Gan VHL; Khor LY
    Ann Clin Lab Sci; 2018 Jan; 48(1):110-115. PubMed ID: 29531006
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Perivascular epithelioid cell tumor (PEComa) of the urinary bladder associated with Xp11 translocation.
    Russell CM; Buethe DD; Dickinson S; Sexton WJ
    Ann Clin Lab Sci; 2014; 44(1):91-8. PubMed ID: 24695481
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hepatic angiomyolipomas may overexpress TFE3, but have no relevant genetic alterations.
    Jimbo N; Nishigami T; Noguchi M; Iijima H; Hirota S; Tajiri T; Inoue T; Hirose T; Itoh T; Zen Y
    Hum Pathol; 2017 Mar; 61():41-48. PubMed ID: 27865795
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Perivascular epithelioid cell tumor of the uterine cervix identified on the liquid-based cytology: a case report.
    Tang X; Feng M; Shen Y; Chen Q
    Diagn Pathol; 2023 Jan; 18(1):7. PubMed ID: 36647157
    [TBL] [Abstract][Full Text] [Related]  

  • 39. TFE3 Gene Rearrangement in Perivascular Epithelioid Cell Neoplasm (PEComa) of the Genitourinary Tract.
    Vannucchi M; Minervini A; Salvi M; Montironi R; Raspollini MR
    Clin Genitourin Cancer; 2020 Dec; 18(6):e692-e697. PubMed ID: 32576448
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Xp11 Translocation Renal Cell Carcinoma and the Mesenchymal Counterparts: An Evolving Concept with Novel Insights on Clinicopathologic Features, Prognosis, Treatment, and Classification.
    Wang XT; Xia QY; Zhou XJ; Rao Q
    Crit Rev Oncog; 2017; 22(5-6):481-497. PubMed ID: 29604926
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.